57 research outputs found

    Development of 100^{100}Mo-containing scintillating bolometers for a high-sensitivity neutrinoless double-beta decay search

    Get PDF
    We report recent achievements in the development of scintillating bolometers to search for neutrinoless double-beta decay of 100^{100}Mo. The presented results have been obtained in the framework of the LUMINEU, LUCIFER and EDELWEISS collaborations, and are now part of the R\&D activities towards CUPID (CUORE Update with Particle IDentification), a proposed next-generation double-beta decay experiment based on the CUORE experience. We have developed a technology for the production of large mass (\sim1 kg), high optical quality, radiopure zinc and lithium molybdate crystal scintillators (ZnMoO4_4 and Li2_2MoO4_4, respectively) from deeply purified natural and 100^{100}Mo-enriched molybdenum. The procedure is applied for a routine production of enriched crystals. Furthermore, the technology of a single detector module consisting of a large-volume (100\sim 100~cm3^3) Zn100^{100}MoO4_4 and Li2_2100^{100}MoO4_4 scintillating bolometer has been established, demonstrating performance and radiopurity that are close to satisfy the demands of CUPID. In particular, the FWHM energy resolution of the detectors at 2615 keV --- near the QQ-value of the double-beta transition of 100^{100}Mo (3034~keV) --- is \approx 4--10~keV. The achieved rejection of α\alpha-induced dominant background above 2.6~MeV is at the level of more than 99.9\%. The bulk activity of 232^{232}Th (228^{228}Th) and 226^{226}Ra in the crystals is below 10 μ\muBq/kg. Both crystallization and detector technologies favor Li2_2MoO4_4, which was selected as a main element for the realization of a CUPID demonstrator (CUPID-0/Mo) with \sim7 kg of 100^{100}Mo

    QCD and strongly coupled gauge theories : challenges and perspectives

    Get PDF
    We highlight the progress, current status, and open challenges of QCD-driven physics, in theory and in experiment. We discuss how the strong interaction is intimately connected to a broad sweep of physical problems, in settings ranging from astrophysics and cosmology to strongly coupled, complex systems in particle and condensed-matter physics, as well as to searches for physics beyond the Standard Model. We also discuss how success in describing the strong interaction impacts other fields, and, in turn, how such subjects can impact studies of the strong interaction. In the course of the work we offer a perspective on the many research streams which flow into and out of QCD, as well as a vision for future developments.Peer reviewe

    Vaccines based on the cell surface carbohydrates of pathogenic bacteria

    Full text link

    Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia.

    Get PDF
    Abstract Background: Tigecycline, an expanded broad-spectrum glycylcycline, exhibits in vitro activity against many common pathogens associated with community-acqui red pneumonia (CAP), as well as penetration into lung tissues that suggests effectiveness in ho spitalized CAP patients. The aim of the present study was to compare the efficacy and safety of intravenous (IV) tigecycline with IV levofloxacin in hospitalized adults with CAP. Methods: In this prospective, double-blin d, non-inferiority phase 3 trial, eligible patients with a clinical diagnosis of CAP supported by radiographic evidence were stratified by Fine Pneumonia Severity Index and randomized to tigecycline or levofloxacin for 7-14 days of therapy. Co-primary efficacy endpoints were clinical response in the clinically evaluable (CE) and clinical modified intent- to-treat (c-mITT) populations at te st-of-cure (Day 10-21 post-therapy). Results: Of the 428 patients who received at least on e dose of study drug, 79% had CAP of mild-moderate severity according to their Fine score. Clinical cure rates for the CE population were 88.9% for tigecycline and 85.3% for levofloxac in. Corresponding c-mITT population rates were 83.7% and 81.5%, respectively. Eradication rates for Streptococcus pneumoniae were 92% for tigecycline and 89% for levofloxac in. Nausea, vomiting, and diarrhoea were the most frequently reported adverse events. Rates of premature disc continuation of study drug or study withdrawal because of any adverse event were similar for both study drugs. Conclusion: These findings suggest that IV tigecycline is non-inferior to IV levofloxacin and is generally well-tolerated in the treatment of hospitalized adults with CAP

    MgWO4-A new crystal scintillator

    No full text
    Magnesium tungstate (MgWO4) crystals of ~1 cm3 volume were obtained for the first time using a flux growth technique. The crystal was subjected to comprehensive characterisation that included room-temperature measurements of the transmittance, X-ray luminescence spectra, afterglow under X-ray excitation, relative photoelectron output, energy resolution, non-proportionality of scintillation response to γ-quanta, response to α-particles, and pulse shape for γ-quanta and α-particles. The light output and decay kinetics of MgWO4 were studied over the temperature range 7-305 K. Under X-ray excitation the crystal exhibits an intense luminescence band peaking at a wavelength of 470 nm; the intensity of afterglow after 20 ms is 0.035%. An energy resolution of 9.1% for 662 keV γ-quanta of 137Cs was measured with a small (≈0.9 g) sample of the MgWO4 crystal. The photoelectron output of the MgWO4 crystal scintillator is 35% that of CdWO4 and 27% that of NaI(Tl). The detector showed pulse-shape discrimination ability in measurements with α-particles and γ-quanta, which enabled us to assess the radioactive contamination of the scintillator. The results of these studies demonstrate the prospect of this material for a variety of scintillation applications, including rare event searches. © 2008 Elsevier B.V
    corecore